Global

‡ In these countries please contact our distributor

Acticoat* Case Study MRomanelli Hip

Smith & Nephew logo

spacer

Acticoat Antimicrobial Barrier Dressing logo

 

Management of a pressure ulcer of the hip with Acticoat* 7 (with SILCRYST TM Nanocrystals)


Introduction
This case study illustrates the use of Acticoat 7 to heal a pressure ulcer that had failed to respond to previous therapy.

 

Patient
The patient was an 85 year old male, who was partially bedridden and suffering from malnutrition and cachexia. A pressure ulcer had formed on the hip and had been present for 5 months. The woundbed was 95% sloughy, with signs and symptoms of infection, including increased redness, increased exudate and pain (Fig. 1). Previous treatment had involved topical antibiotics and gauze. A deep swab revealed the presence of Staphylococcus aureus, prompting administration of systemic antibiotics twice daily for 7 days.

 

Treatment
Acticoat 7 was moistened, applied to the wound and covered with Allevyn*. Dressing changes were carried out every 7 days.

 

Outcome
A visual difference could be seen after 20 days (Fig. 2) and complete healing was achieved in 5 weeks (Fig. 3).

 

Fig 1 Fig 2
 
Fig 3  

 The patient had approximately 5 months of conventional treatment for his grade 3 pressure ulcer, with the ulcer remaining unhealed.

 

A 5-piece course of Acticoat 7 resulted in a healed ulcer within 5 weeks.

 


Nanocrystalline Silver is a patented technology of NUCRYST Pharmaceuticals Corp.
TM SILCRYST is a trademark of NUCRYST Pharmaceuticals Corp, used under licence